From Node to Pathway Blockade: Lessons Learned From Targeting Mammalian Target of RapamycinHIDALGO, Manuel.Journal of clinical oncology. 2012, Vol 30, Num 1, pp 85-87, issn 0732-183X, 3 p.Article

Lovastatin induces VSMC differentiation through inhibition of Rheb and mTORWAGNER, Robert J; MARTIN, Kathleen A; POWELL, Richard J et al.American journal of physiology. Cell physiology. 2010, Vol 68, Num 1, issn 0363-6143, C119-C127Article

Placental DEPTOR as a stress sensor during pregnancyMPARMPAKAS, Dionisis; ZACHARIADES, Elena; GOUMENOU, Anastasia et al.Clinical science (1979). 2012, Vol 122, Num 7-8, pp 349-359, issn 0143-5221, 11 p.Article

The α7β1-integrin accelerates fiber hypertrophy and myogenesis following a single bout of eccentric exerciseLUEDERS, Tara N; ZOU, Kai; HUNTSMAN, Heather D et al.American journal of physiology. Cell physiology. 2011, Vol 70, Num 4, issn 0363-6143, C938-C946Article

Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine TumorsZHI RONG QIAN; TER-MINASSIAN, Monica; XIHONG LIN et al.Journal of clinical oncology. 2013, Vol 31, Num 27, pp 3418-3425, issn 0732-183X, 8 p.Article

Spatial Coupling of mTOR and Autophagy Augments Secretory PhenotypesNARITA, Masako; YOUNG, Andrew R. J; TAVARE, Simon et al.Science (Washington, D.C.). 2011, Vol 332, Num 6032, pp 966-970, issn 0036-8075, 5 p.Article

Temsirolimus, an Inhibitor of Mammalian Target of RapamycinRINI, Brian I.Clinical cancer research. 2008, Vol 14, Num 5, pp 1286-1290, issn 1078-0432, 5 p.Article

Prognostic Impact of the Activation Status of the Akt/mTOR Pathway in Synovial SarcomaSETSU, Nokitaka; KOHASHI, Kenichi; ODA, Yoshinao et al.Cancer. 2013, Vol 119, Num 19, pp 3504-3513, issn 0008-543X, 10 p.Article

Preliminary Characterization of Oral Lesions Associated With Inhibitors of Mammalian Target of Rapamycin in Cancer PatientsSONIS, Stephen; TREISTER, Nathaniel; CHAWLA, Sant et al.Cancer. 2010, Vol 116, Num 1, pp 210-215, issn 0008-543X, 6 p.Article

A GSK-3/TSC2/mTOR pathway regulates glucose uptake and GLUT1 glucose transporter expressionBULLER, Carolyn L; LOBERG, Robert D; FAN, Ming-Hui et al.American journal of physiology. Cell physiology. 2008, Vol 64, Num 3, issn 0363-6143, C836-C843Article

Leucine stimulates mammalian target of rapamycin signaling in C2C12 myoblasts in part through inhibition of adenosine monophosphate-activated protein kinaseDU, M; SHEN, Q. W; ZHU, M. J et al.Journal of animal science. 2007, Vol 85, Num 4, pp 919-927, issn 0021-8812, 9 p.Article

Inhibition of voltage-gated K⁺ channels in dendritic cells by rapamycinTYAN, Leonid; SOPJANI, Mentor; DËRMAKU-SOPJANI, Miribane et al.American journal of physiology. Cell physiology. 2010, Vol 68, Num 6, issn 0363-6143, C1379-C1385Article

mTOR attenuates the inflammatory response in cardiomyocytes and prevents cardiac dysfunction in pathological hypertrophyXIAOXIAO SONG; KUSAKARI, Yoichiro; XIAO, Chun-Yang et al.American journal of physiology. Cell physiology. 2010, Vol 68, Num 6, issn 0363-6143, C1256-C1266Article

The effect of rapamycin on DNA synthesis in multiple tissues from late gestation fetal and postnatal ratsSANDERS, Jennifer A; LAKHANI, Alisha; PHORNPHUTKUL, Chanika et al.American journal of physiology. Cell physiology. 2008, Vol 64, Num 2, pp 406-413, issn 0363-6143, 8 p.Article

Nutrient availability and lactogenic hormones regulate mammary protein synthesis through the mammalian target of rapamycin signaling pathwayBURGOS, S. A; DAI, M; CANT, J. P et al.Journal of dairy science. 2010, Vol 93, Num 1, pp 153-161, issn 0022-0302, 9 p.Article

Leucine and protein synthesis : mTOR and beyondSTIPANUK, Martha H.Nutrition reviews. 2007, Vol 65, Num 3, pp 122-129, issn 0029-6643, 8 p.Article

Akt promotes increased mammalian cell size by stimulating protein synthesis and inhibiting protein degradationFARIDI, Jesika; FAWCETT, Janet; LIHONG WANG et al.American journal of physiology. Endocrinology and metabolism. 2003, Vol 48, Num 5, pp E964-E972, issn 0193-1849Article

Radioresistant Cancer Cells Can Be Conditioned to Enter Senescence by mTOR InhibitionHAE YUN NAM; MYUNG WOUL HAN; HYESUNG JEON et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4267-4277, issn 0008-5472, 11 p.Article

Lactate Dehydrogenase B Is Critical for Hyperactive mTOR-Mediated TumorigenesisXIAOJUN ZHA; FANG WANG; YING WANG et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 1, pp 13-18, issn 0008-5472, 6 p.Article

Curcumin Disrupts the Mammalian Target of Rapamycin-Raptor ComplexBEEVERS, Christopher S; LONG CHEN; LEI LIU et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 3, pp 1000-1008, issn 0008-5472, 9 p.Article

Inhibitors of the Mammalian Target of Rapamycin and Transplant ToleranceBESTARD, Oriol; CRUZADO, Josep M; GRINYO, Josep M et al.Transplantation. 2009, Vol 87, Num 8S, issn 0041-1337, S27-S29, SUPArticle

Inhibition of mTOR blocks the anti-inflammatory effects of glucocorticoids in myeloid immune cellsWEICHHART, Thomas; HAIDINGER, Michael; HÖRL, Walter H et al.Blood. 2011, Vol 117, Num 16, pp 4273-4283, issn 0006-4971, 11 p.Article

Exploiting Tumor Vulnerabilities: Epigenetics, Cancer Metabolism and the mTOR Pathway in the Era of Personalized MedicineMUNOZ-PINEDO, Cristina; GONZALEZ-SUAREZ, Eva; PORTELA, Anna et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 14, pp 4185-4189, issn 0008-5472, 5 p.Article

MTOR-What Does It Do?HALL, M. N.Transplantation proceedings. 2008, Vol 40, Num 10, issn 0041-1345, S5-S8, SUPConference Paper

Mammalian target of rapamycin regulates neutrophil extracellular trap formation via induction of hypoxia-inducible factor 1 alphaMCLNTURFF, Alison M; CODY, Mark J; ELLIOTT, Elizabeth A et al.Blood. 2012, Vol 120, Num 15, pp 3118-3125, issn 0006-4971, 8 p.Article